Concepedia

Vedika Mehra

VM

Statistics

Publications

4

Citations

205

H-Index

4

Active since

2016

Affiliations

University College London(Current)

Autolus (United Kingdom)

The Royal Free Hospital

CRUK Lung Cancer Centre of Excellence

Vedika Mehra is an author at University College London specializing in oncology, car t cell trials, and chimeric antigen receptor t-cell therapy.

Publications per year

2016–2024

4

Publications

4

Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Claire Roddie, Juliana Dias, Maeve O’Reilly et al. · Journal of Clinical Oncology · 2021 · 142 citations · Full text

Medicine, Hematology, Oncology +17

AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival

Vedika Mehra, Giulia Agliardi, Juliana Dias et al. · Journal for ImmunoTherapy of Cancer · 2023 · 29 citations · Full text

Life Sciences, Immunology, Oncology +17

Short SULF1/SULF2 splice variants predominate in mammary tumours with a potential to facilitate receptor tyrosine kinase-mediated cell signalling

Roop Gill, Vedika Mehra, Emma Milford et al. · Histochemistry and Cell Biology · 2016 · 17 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Current Treatment Options for Renal Cell Carcinoma: Focus on Cell-Based Immunotherapy

Angela Hwang, Vedika Mehra, Jyoti Chhetri et al. · Cancers · 2024 · 17 citations · Full text

Medicine, Immunology, Oncology +17

1–4 of 4